A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)

Chiorazzi, 2005, Chronic lymphocytic leukemia, N. Engl. J. Med., 352, 804, 10.1056/NEJMra041720 Keating, 1999, Chronic lymphocytic leukemia, Semin. Oncol., 26, 107 Hallek, 2008, Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, Blood, 111, 5446, 10.1182/blood-2007-06-093906 Kempin, 2013, Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis, Curr. Treat. Options in Oncol., 14, 144, 10.1007/s11864-013-0229-5 Herman, 2016, Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade, Semin. Oncol., 43, 222, 10.1053/j.seminoncol.2016.02.007 Bichi, 2002, Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression, Proc. Natl. Acad. Sci. U. S. A., 99, 6955, 10.1073/pnas.102181599 Zapata, 2004, TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 101, 16600, 10.1073/pnas.0407541101 Klein, 2010, The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia, Cancer Cell, 17, 28, 10.1016/j.ccr.2009.11.019 Shukla, 2013, A role for IRF4 in the development of CLL, Blood, 122, 2848, 10.1182/blood-2013-03-492769 Durig, 2007, A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease, Cancer Res., 67, 8653, 10.1158/0008-5472.CAN-07-1198 Bagnara, 2011, A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease, Blood, 117, 5463, 10.1182/blood-2010-12-324210 Herman, 2013, Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy, Leukemia, 27, 2311, 10.1038/leu.2013.131 Mavromatis, 2002, Pre- and post-treatment evaluation of non-Hodgkin's lymphoma, Best Pract. Res. Clin. Haematol., 15, 429, 10.1053/beha.2002.0217 Cheson, 1996, National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment, Blood, 87, 4990, 10.1182/blood.V87.12.4990.bloodjournal87124990 Eichhorst, 2011, Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis, Blood, 117, 1817, 10.1182/blood-2010-04-282228 Byrd, 2014, A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia, Blood, 123, 1302, 10.1182/blood-2013-07-512137 Gentile, 2016, Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study, Eur. J. Haematol., 96, 36, 10.1111/ejh.12545 Froehlich, 2012, Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?, Contrast Media Mol. Imaging, 7, 346, 10.1002/cmmi.503 Weissleder, 1990, Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging, Radiology, 175, 489, 10.1148/radiology.175.2.2326474 Weissleder, 1988, Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging, Radiology, 169, 399, 10.1148/radiology.169.2.3174987 Wadghiri, 2013, Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging, PLoS One, 8, e57097, 10.1371/journal.pone.0057097 Crimi, 2014, Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning, PLoS One, 9, e93024, 10.1371/journal.pone.0093024 Tourdias, 2012, Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging, Radiology, 264, 225, 10.1148/radiol.12111416 Marinescu, 2013, Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI, Eur. Radiol., 23, 37, 10.1007/s00330-012-2567-2 Wu, 2009, Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance, JACC Cardiovasc. Imaging, 2, 731, 10.1016/j.jcmg.2009.01.013 Lutz, 2004, Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging, Radiology, 233, 149, 10.1148/radiol.2331031402 Tsuchiya, 2013, Atherosclerotic imaging using 4 types of superparamagnetic iron oxides: new possibilities for mannan-coated particles, Eur. J. Radiol., 82, 1919, 10.1016/j.ejrad.2013.07.017 Bremer, 1999, RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography, J. Magn. Reson. Imaging, 10, 461, 10.1002/(SICI)1522-2586(199909)10:3<461::AID-JMRI30>3.0.CO;2-5 Metz, 2004, Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro, Eur. Radiol., 14, 1851, 10.1007/s00330-004-2405-2 Gellissen, 1999, Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging, Magn. Reson. Imaging, 17, 557, 10.1016/S0730-725X(98)00206-9 Morabito, 2015, Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study, Br. J. Haematol., 168, 455, 10.1111/bjh.13117 Morabito, 2013, Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features, Clin. Cancer Res., 19, 5890, 10.1158/1078-0432.CCR-13-0622 Foster-Gareau, 2003, Imaging single mammalian cells with a 1.5T clinical MRI scanner, Magn. Reson. Med., 49, 968, 10.1002/mrm.10417 Wolff, 1997, Assessing contrast on MR images, Radiology, 202, 25, 10.1148/radiology.202.1.8988186 Daldrup-Link, 2005, Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment, Radiology, 234, 197, 10.1148/radiol.2341031236 Wong, 2012, Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice, Cancer Res., 72, 4931, 10.1158/0008-5472.CAN-12-1390 Baio, 2006, Magnetic resonance imaging at 1.5T with immunospecific contrast agent in vitro and in vivo in a xenotransplant model, MAGMA, 19, 313, 10.1007/s10334-006-0059-6 Simon, 2006, T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning, Eur. Radiol., 16, 738, 10.1007/s00330-005-0031-2 Patten, 2016, Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process, JCI Insight, 1, 10.1172/jci.insight.86288